{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:33:10Z","timestamp":1791919990433,"version":"4.3.4"},"reference-count":181,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"vor","delay-in-days":717,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/25112\u20134"],"award-info":[{"award-number":["2016\/25112\u20134"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/25747\u20135"],"award-info":[{"award-number":["2018\/25747\u20135"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/05936\u20130"],"award-info":[{"award-number":["2019\/05936\u20130"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["305672\/2019\u20132"],"award-info":[{"award-number":["305672\/2019\u20132"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["312020\/2019-8"],"award-info":[{"award-number":["312020\/2019-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.bmc.2021.116365","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T18:46:18Z","timestamp":1628880378000},"page":"116365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Cysteine proteases as potential targets for anti-trypanosomatid drug discovery"],"prefix":"10.1016","volume":"46","author":[{"given":"Wagner A.S.","family":"Judice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia Silva","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayssa de Mello","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luan dos Santos","family":"Vianna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio da Silva","family":"Siqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana F.","family":"Di Iorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura de Azevedo Maffeis","family":"Dalzoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Nascimento Romero","family":"Trujilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiz dos Reis","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maur\u00edcio F.M.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2021.116365_b0005","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2021.116365_b0010","doi-asserted-by":"crossref","unstructured":"Book Review: Working to Overcome the Global Impact of Neglected Tropical Diseases. Perspect Public Health. 2012;132(4):192\u20132. http:\/\/doi.org\/10.1177\/1757913912449575.","DOI":"10.1177\/1757913912449575"},{"key":"10.1016\/j.bmc.2021.116365_b0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16111925","article-title":"Emerging resistance of neglected tropical diseases: A scoping review of the literature","volume":"16","author":"Akinsolu","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.bmc.2021.116365_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-017-2028-5","article-title":"The history of leishmaniasis","volume":"10","author":"Steverding","year":"2017","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.bmc.2021.116365_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004349","article-title":"A Historical Overview of the Classification, Evolution, and Dispersion of Leishmania Parasites and Sandflies","volume":"10","author":"Akhoundi","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmc.2021.116365_b0030","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0738-081X(99)00046-2","article-title":"The biology and control of Phlebotomine sand flies","volume":"17","author":"Killick-Kendrick","year":"1999","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.bmc.2021.116365_b0035","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"Reithinger","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bmc.2021.116365_b0040","unstructured":"World Helth Organization \u2013 Leishmaniasis: Vector control, 2018. - Pesquisa Google. Accessed March 23, 2021. https:\/\/www.google.com\/search?q=World+Helth+Organization+\u2013+Leishmaniasis%3A+Vector+control%2C+2018.&rlz=1C5CHFA_enBR824BR824&oq=World+Helth+Organization+\u2013+Leishmaniasis%3A+Vector+control%2C+2018.&aqs=chrome..69i57.1161j0j9&sourceid=chrome&ie=UTF-8."},{"key":"10.1016\/j.bmc.2021.116365_b0045","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2021.116365_b0050","unstructured":"Lainson R, Shaw JJ. Evolution, classification and geographical distribution. In: The Leishmaniases in Biology and Medicine. Volume I. Biology and Epidemiology. ; 1987."},{"key":"10.1016\/j.bmc.2021.116365_b0055","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1086\/518041","article-title":"Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis","volume":"195","author":"Arevalo","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bmc.2021.116365_b0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1590\/S0074-02762001000200005","article-title":"Clinical Picture of Cutaneous Leishmaniases Due to Leishmania (Leishmania) Mexicana in the Yucatan Peninsula Mexico","volume":"96","author":"Andrade-Narv\u00e1ez","year":"2001","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.bmc.2021.116365_b0065","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1128\/AEM.66.5.1933-1938.2000","article-title":"Detection and identification of Leishmania DNA within naturally infected sand flies by seminested PCR on minicircle kinetoplastic DNA","volume":"66","author":"Aransay","year":"2000","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.bmc.2021.116365_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000555","article-title":"Proteophosophoglycans regurgitated by Leishmania-infected sand flies target the L-arginine metabolism of host macrophages to promote parasite survival","volume":"5","author":"Rogers","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bmc.2021.116365_b0075","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.micinf.2010.05.014","article-title":"Leishmania infantum proteophosphoglycans regurgitated by the bite of its natural sand fly vector, Lutzomyia longipalpis, promote parasite establishment in mouse skin and skin-distant tissues","volume":"12","author":"Rogers","year":"2010","journal-title":"Microbes Infect"},{"key":"10.1016\/j.bmc.2021.116365_b0080","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez NE, Dixit UG, Allen L-AH, Wilson ME. Stage-Specific Pathways of Leishmania infantum chagasi Entry and Phagosome Maturation in Macrophages. Macrophages PLoS ONE. 2011;6(4):19000. http:\/\/doi.org\/10.1371\/journal.pone.0019000.","DOI":"10.1371\/journal.pone.0019000"},{"key":"10.1016\/j.bmc.2021.116365_b0085","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41564-018-0125-7","article-title":"Sequential blood meals promote Leishmania replication and reverse metacyclogenesis augmenting vector infectivity","volume":"3","author":"Serafim","year":"2018","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.bmc.2021.116365_b0090","first-page":"44","article-title":"Molecular and Cellular Biochemistry Faculty Publications","volume":"6","author":"Ramiro Assis","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmc.2021.116365_b0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fcimb.2012.00121","article-title":"Leishmania promastigotes: building a safe niche within macrophages","volume":"2","author":"Moradin","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.bmc.2021.116365_b0100","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.micinf.2012.05.014","article-title":"Leishmania virulence factors: Focus on the metalloprotease GP63","volume":"14","author":"Olivier","year":"2012","journal-title":"Microbes Infect"},{"key":"10.1016\/j.bmc.2021.116365_b0105","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3201\/eid0906.030026","article-title":"Anthroponotic cutaneous leishmaniasis, Kabul Afghanistan","volume":"9","author":"Reithinger","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bmc.2021.116365_b0110","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3201\/eid1009.040179","article-title":"Leishmaniasis in refugee and local Pakistani populations","volume":"10","author":"Brooker","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bmc.2021.116365_b0115","article-title":"Clinical manifestations and classification of Old World cutaneous leishmaniasis Clinical trials in CTCL View project Empiric Treatment for Serious Bacterial Infections View project","author":"Akilov","year":"2007","journal-title":"Artic Int J Dermatology Published online"},{"key":"10.1016\/j.bmc.2021.116365_b0120","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ijpara.2007.04.007","article-title":"The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist","volume":"37","author":"Kima","year":"2007","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.bmc.2021.116365_b0125","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: Current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.bmc.2021.116365_b0130","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S1473-3099(02)00372-9","article-title":"Malaria: Current status of control, diagnosis, treatment, and a proposed agenda for research and development","volume":"2","author":"Guerin","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bmc.2021.116365_b0135","doi-asserted-by":"crossref","unstructured":"Sousa F das CA, Soares HVA, Lemos LEAS, Reis DM, Silva WC da, Rodrigues LA de S. Perfil epidemiol\u00f3gico de doen\u00e7as negligenciadas de notifica\u00e7\u00e3o compuls\u00f3ria no Brasil com an\u00e1lise dos investimentos governamentais nessa \u00e1rea. Res Soc Dev. 2020;9(1):e62911610. http:\/\/doi.org\/10.33448\/rsd-v9i1.1610.","DOI":"10.33448\/rsd-v9i1.1610"},{"key":"10.1016\/j.bmc.2021.116365_b0140","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1089\/vbz.2018.2266","article-title":"First report of natural infection with trypanosoma cruzi in rhodnius montenegrensis (Hemiptera, Reduviidae, Triatominae) in Western Amazon Brazil","volume":"18","author":"Bilheiro","year":"2018","journal-title":"Vector-Borne Zoonotic Dis"},{"key":"10.1016\/j.bmc.2021.116365_b0145","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1590\/S0074-02761909000200008","article-title":"Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem","volume":"1","author":"Chagas","year":"1909","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.bmc.2021.116365_b0150","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"Rassi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2021.116365_b0155","doi-asserted-by":"crossref","unstructured":"Tyler KM, Engman DM. The life cycle of Trypanosoma cruzi revisited. In: International Journal for Parasitology. Vol. 2001:472\u201381. http:\/\/doi.org\/10.1016\/S0020-7519(01)00153-9.","DOI":"10.1016\/S0020-7519(01)00153-9"},{"key":"10.1016\/j.bmc.2021.116365_b0160","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.mi.49.100195.001135","article-title":"The mechanisms of Trypanosoma cruzi invasion of mammalian cells","volume":"49","author":"Burleigh","year":"1995","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.bmc.2021.116365_b0165","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/CMR.00005-11","article-title":"Trypanosoma cruzi and chagas\u2019 disease in the united states","volume":"24","author":"Bern","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bmc.2021.116365_b0170","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0002-9440(10)65052-3","article-title":"Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic chagas disease: Differential distribution of genetic types into diverse organs","volume":"156","author":"Vago","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bmc.2021.116365_b0175","doi-asserted-by":"crossref","unstructured":"Barbosa-Ferreira JM, Guerra JA de O, Santana Filho FS de, Magalh\u00e3es BML, Coelho LIARC, Barbosa M das GV. [Cardiac involvement in Acute Chagas\u2019 Disease cases in the Amazon region]. Arq Bras Cardiol. 2010;94(6). http:\/\/doi.org\/10.1590\/s0066-782x2010000600023.","DOI":"10.1590\/S0066-782X2010000600023"},{"key":"10.1016\/j.bmc.2021.116365_b0180","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1590\/S0037-86822011005000002","article-title":"Qualidade de vida relacionada \u00e0 sa\u00fade na doen\u00e7a de Chagas","volume":"44","author":"Oliveira","year":"2011","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.bmc.2021.116365_b0185","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9014726","article-title":"Pentavalent antimonials combined with other therapeutic alternatives for the treatment of cutaneous and mucocutaneous leishmaniasis: A systematic review","volume":"2018","author":"Berbert","year":"2018","journal-title":"Dermatol Res Pract"},{"key":"10.1016\/j.bmc.2021.116365_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006969","article-title":"Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening","volume":"12","author":"Turcano","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmc.2021.116365_b0195","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","article-title":"Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World","volume":"118","author":"Oliveira","year":"2011","journal-title":"Acta Trop"},{"key":"10.1016\/j.bmc.2021.116365_b0200","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/clinids\/18.1.83","article-title":"Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis","volume":"18","author":"Gasser","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmc.2021.116365_b0205","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/617521","article-title":"Drug resistance in visceral leishmaniasis","volume":"2010","author":"Maltezou","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.bmc.2021.116365_b0210","unstructured":"Singh N. Drug resistance mechanisms in clinical isolates of Leishmania donovani. Indian J Med Res. 2006;123(3):411-422. Accessed March 24, 2021. https:\/\/citeseerx.ist.psu.edu\/viewdoc\/download?doi=10.1.1.490.4804&rep=rep1&type=pdf."},{"key":"10.1016\/j.bmc.2021.116365_b0215","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-014-0596-1","article-title":"The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India","volume":"7","author":"Singh","year":"2014","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.bmc.2021.116365_b0220","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: Report from the center of the Indian epidemic","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmc.2021.116365_b0225","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1128\/AAC.00404-07","article-title":"Role of the ABC transporter PRP1 (ABCC7) in pentamidine resistance in Leishmania amastigotes","volume":"51","author":"Coelho","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2021.116365_b0230","doi-asserted-by":"crossref","first-page":"10996","DOI":"10.1073\/pnas.1202885109","article-title":"Aquaglyceroporin 2 controls susceptibility to melarsoprol and pentamidine in African trypanosomes","volume":"109","author":"Baker","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2021.116365_b0235","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0035-9203(83)90058-5","article-title":"Evaluation of diamidine compound (pentamidine isethionate) in the treatment of resistant cases of kala-azar occurring in North Bihar, India","volume":"77","author":"Jha","year":"1983","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.bmc.2021.116365_b0240","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003495-200969030-00010","article-title":"Liposomal amphotericin B: A review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections","volume":"69","author":"Moen","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2021.116365_b0245","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/0006-2952(87)90543-0","article-title":"The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani","volume":"36","author":"Croft","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2021.116365_b0250","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1128\/AAC.36.8.1630","article-title":"Hexadecylphosphocholine: Oral treatment of visceral leishmaniasis in mice","volume":"36","author":"Kuhlencord","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2021.116365_b0255","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0140-6736(98)04367-0","article-title":"Trial of oral miltefosine for visceral leishmaniasis","volume":"352","author":"Sundar","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2021.116365_b0260","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJM199912093412403","article-title":"Miltefosine, an Oral Agent, for the Treatment of Indian Visceral Leishmaniasis","volume":"341","author":"Jha","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2021.116365_b0265","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/0974-777X.62886","article-title":"Liposomal amphotericin B and leishmaniasis: Dose and response","volume":"2","author":"Sundar","year":"2010","journal-title":"J Glob Infect Dis"},{"key":"10.1016\/j.bmc.2021.116365_b0270","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijpddr.2018.04.001","article-title":"Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome\u00ae and Am Bisome\u00ae in murine cutaneous leishmaniasis","volume":"8","author":"Wijnant","year":"2018","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.bmc.2021.116365_b0275","unstructured":"Adler-Moore J, Proffitt RT. Effect of tissue penetration on AmBisome efficacy. Curr Opin Investig Drugs. 2003;4(2):179-185. Accessed March 25, 2021. https:\/\/www.researchgate.net\/publication\/10828143."},{"key":"10.1016\/j.bmc.2021.116365_b0280","doi-asserted-by":"crossref","unstructured":"Adler-Moore J, Proffitt RT. AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience. J Antimicrob Chemother. 2002;49(suppl_1):21-30. Accessed March 25, 2021. https:\/\/academic.oup.com\/jac\/article-abstract\/49\/suppl_1\/21\/2473432.","DOI":"10.1093\/jac\/49.suppl_1.21"},{"key":"10.1016\/j.bmc.2021.116365_b0285","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/380971","article-title":"Amphotericin B Treatment for Indian Visceral Leishmaniasis: Conventional versus Lipid Formulations","volume":"38","author":"Sundar","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmc.2021.116365_b0290","doi-asserted-by":"crossref","first-page":"374","DOI":"10.5935\/1984-6835.20120029","article-title":"Trypanosomatids metabolic systems as potential chemotherapeutic targets","volume":"4","author":"Melos","year":"2012","journal-title":"Rev Virtual Quim"},{"key":"10.1016\/j.bmc.2021.116365_b0295","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1590\/S0100-40422009000900038","article-title":"Quimioterapia da doen\u00e7a de Chagas: estado da arte e perspectivas no desenvolvimento de novos f\u00e1rmacos","volume":"32","author":"Dias","year":"2009","journal-title":"Quim Nova"},{"key":"10.1016\/j.bmc.2021.116365_b0300","unstructured":"Roberts SC. Genetic Manipulation of Leishmania Parasites Facilitates the Exploration of the Polyamine Biosynthetic Pathway as a Potential Therapeutic Target. Adv Genet Reseach. 2013;10:29-54. Accessed March 25, 2021. http:\/\/commons.pacificu.edu\/phrmfac."},{"key":"10.1016\/j.bmc.2021.116365_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20121743","article-title":"The glyoxalase pathway: The first hundred years... and beyond","volume":"453","author":"Sousa Silva","year":"2013","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2021.116365_b0310","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.molbiopara.2009.12.004","article-title":"Phospholipid and sphingolipid metabolism in Leishmania","volume":"170","author":"Zhang","year":"2010","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bmc.2021.116365_b0315","unstructured":"Abu-Mejdad N. Evaluation of therapeutic effects of vicine against leishmania donovani. in vitro. J Am Sci. 2013;9(5):115-20. Accessed March 25, 2021. http:\/\/www.jof."},{"key":"10.1016\/j.bmc.2021.116365_b0320","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/187152008783497064","article-title":"Recent Advances in Classical and Non-Classical Antifolates as Antitumor and Antiopportunistic Infection Agents: Part II","volume":"8","author":"Gangjee","year":"2008","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.bmc.2021.116365_b0325","doi-asserted-by":"crossref","first-page":"4460","DOI":"10.4049\/jimmunol.1103072","article-title":"Heme Oxygenase-1 Promotes the Persistence of Leishmania chagasi Infection","volume":"188","author":"Luz","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.bmc.2021.116365_b0330","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbrc.2012.03.107","article-title":"Identification and characterization of a novel Ribose 5-phosphate isomerase B from Leishmania donovani","volume":"421","author":"Kaur","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2021.116365_b0335","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.biochi.2012.04.003","article-title":"Crystal structure of dihydroorotate dehydrogenase from Leishmania major","volume":"94","author":"Cordeiro","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.bmc.2021.116365_b0340","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-3024.2012.01361.x","article-title":"Characterization of Leishmania infantum thiol-dependent reductase 1 and evaluation of its potential to induce immune protection","volume":"34","author":"Silva","year":"2012","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.bmc.2021.116365_b0345","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.1016\/j.bmcl.2012.09.044","article-title":"Recent results in protein kinase inhibition for tropical diseases","volume":"22","author":"Rotella","year":"2012","journal-title":"Bioorganic Med Chem Lett"},{"key":"10.1016\/j.bmc.2021.116365_b0350","first-page":"1476","article-title":"A leishmaniasis study: Structure-based screening and molecular dynamics mechanistic analysis for discovering potent inhibitors of spermidine synthase","volume":"2012","author":"Grover","year":"1824","journal-title":"Biochimica et Biophysica Acta - Proteins and Proteomics"},{"key":"10.1016\/j.bmc.2021.116365_b0355","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1590\/S0074-02762009000900042","article-title":"The Benefit trial: Testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease","volume":"104","author":"Antonio Marin-Neto","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.bmc.2021.116365_b0360","doi-asserted-by":"crossref","DOI":"10.1111\/jeu.12184","article-title":"Recent clinical trials for the etiological treatment of chronic chagas disease: Advances, challenges and perspectives","volume":"62","author":"Urbina","year":"2015","journal-title":"J Eukaryot Microbiol"},{"key":"10.1016\/j.bmc.2021.116365_b0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000740","article-title":"In Vitro and In Vivo High-throughput assays for the testing of Anti-trypanosoma cruzi compounds","volume":"4","author":"Canavaci","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmc.2021.116365_b0370","doi-asserted-by":"crossref","unstructured":"Moraes CB, Giardini MA, Kim H, et al. Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: Implications for Chagas disease drug discovery and development. Sci Rep. 2014;4. http:\/\/doi.org\/10.1038\/srep04703.","DOI":"10.1038\/srep04703"},{"key":"10.1016\/j.bmc.2021.116365_b0375","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1056\/NEJMc1514453","article-title":"Benznidazole for Chronic Chagas\u2019 Cardiomyopathy","volume":"374","author":"Urbina","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2021.116365_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2016.09.010","article-title":"Changes in the immune response after treatment with benznidazole versus no treatment in patients with chronic indeterminate Chagas disease","volume":"164","author":"Vallejo","year":"2016","journal-title":"Acta Trop"},{"key":"10.1016\/j.bmc.2021.116365_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(17)30538-8","article-title":"Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial","volume":"18","author":"Torrico","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bmc.2021.116365_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(20)30844-6","article-title":"New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial","author":"Torrico","year":"2021","journal-title":"Lancet Infect Dis Published online"},{"key":"10.1016\/j.bmc.2021.116365_b0395","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2147\/DDDT.S8338","article-title":"Current and developing therapeutic agents in the treatment of Chagas disease","volume":"4","author":"Apt","year":"2010","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.bmc.2021.116365_b0400","doi-asserted-by":"crossref","DOI":"10.1006\/jmbi.1994.0083","article-title":"Alignment\/phylogeny of the papain superfamily of cysteine proteases","volume":"246","author":"Berti","year":"1995","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmc.2021.116365_b0405","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00107","article-title":"Cysteine proteases: Modes of activation and future prospects as pharmacological targets","volume":"7","author":"Verma","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2021.116365_b0410","doi-asserted-by":"crossref","DOI":"10.1002\/j.1460-2075.1996.tb00934.x","article-title":"Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment","volume":"15","author":"Coulombe","year":"1996","journal-title":"EMBO J"},{"key":"10.1016\/j.bmc.2021.116365_b0415","article-title":"and a comparison with peptidases in the PANTHER database","volume":"2018","author":"Rawlings","year":"2017","journal-title":"Nucleic Acids Res Published online"},{"key":"10.1016\/j.bmc.2021.116365_b0420","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.93.12.6008","article-title":"Evidence from disruption of the lmcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors","volume":"93","author":"Mottram","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2021.116365_b0425","doi-asserted-by":"crossref","DOI":"10.1007\/s004300100076","article-title":"Leishmania infection and virulence","volume":"190","author":"Matlashewski","year":"2001","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.bmc.2021.116365_b0430","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.96.20.11015","article-title":"Cysteine protease inhibitors as chemotherapy: Lessons from a parasite target","volume":"96","author":"Selzer","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2021.116365_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/0166-6851(81)90003-7","article-title":"Proteinases of Leishmania mexicana amastigotes and promastigotes: Analysis by gel electrophoresis","volume":"3","author":"North","year":"1981","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bmc.2021.116365_b0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006512","article-title":"Cysteine proteases in protozoan parasites","volume":"12","author":"Siqueira-Neto","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmc.2021.116365_b0445","article-title":"Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells","volume":"108","author":"De Souza","year":"1995","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bmc.2021.116365_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.molbiopara.2005.07.004","article-title":"Specific negative charges in cysteine protease isoforms of Leishmania mexicana are highly influential on the substrate binding and hydrolysis","volume":"144","author":"Judice","year":"2005","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bmc.2021.116365_b0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080153","article-title":"Heparin modulates the endopeptidase activity of Leishmania mexicana cysteine protease cathepsin L-like rCPB2.8","volume":"8","author":"Judice","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmc.2021.116365_b0460","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.01274-07","article-title":"Fibronectin binding and proteolytic degradation by Leishmania and effects on macrophage activation","volume":"76","author":"Kulkarni","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.bmc.2021.116365_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.molbiopara.2012.04.012","article-title":"Leishmania (L.) amazonensis peptidase activities inside the living cells and in their lysates","volume":"184","author":"Caroselli","year":"2012","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bmc.2021.116365_b0470","doi-asserted-by":"crossref","DOI":"10.1111\/j.1432-1033.2004.04008.x","article-title":"Carboxydipeptidase activities of recombinant cysteine peptidases Cruzain of Trypanosoma cruzi and CPB of Leishmania mexicana","volume":"271","author":"Judice","year":"2004","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bmc.2021.116365_b0475","article-title":"Hsp90 Is Involved in Apoptosis of Candida albicans by Regulating the Calcineurin-Caspase Apoptotic Pathway","volume":"7","author":"Di","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmc.2021.116365_b0480","doi-asserted-by":"crossref","DOI":"10.1093\/jxb\/erz082","article-title":"Evolution and structural diversity of metacaspases","author":"Klemen\u010di\u010d","year":"2019","journal-title":"J Exp Bot Published online"},{"key":"10.1016\/j.bmc.2021.116365_b0485","article-title":"Identification of paracaspases and metacaspases: Two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma","author":"Uren","year":"2000","journal-title":"Mol Cell Published online"},{"key":"10.1016\/j.bmc.2021.116365_b0490","doi-asserted-by":"crossref","DOI":"10.1038\/ncb1979","article-title":"Tudor staphylococcal nuclease is an evolutionarily conserved component of the programmed cell death degradome","author":"Sundstr\u00f6m","year":"2009","journal-title":"Nat Cell Biol Published online"},{"key":"10.1016\/j.bmc.2021.116365_b0495","doi-asserted-by":"crossref","DOI":"10.1126\/science.1373520","article-title":"Molecular cloning of the interleukin-1\u03b2 converting enzyme","volume":"256","author":"Cerretti","year":"1992","journal-title":"Science (80-)"},{"key":"10.1016\/j.bmc.2021.116365_b0500","doi-asserted-by":"crossref","DOI":"10.1126\/science.1099320","article-title":"The pathophysiology of mitochondrial cell death","volume":"305","author":"Green","year":"2004","journal-title":"Science (80-)"},{"key":"10.1016\/j.bmc.2021.116365_b0505","doi-asserted-by":"crossref","DOI":"10.1002\/prot.10060","article-title":"Classification of the caspase-hemoglobinase fold: Detection of new families and implications for the origin of the eukaryotic separins","volume":"46","author":"Aravind","year":"2002","journal-title":"Proteins Struct Funct Genet"},{"key":"10.1016\/j.bmc.2021.116365_b0510","doi-asserted-by":"crossref","DOI":"10.1111\/febs.12248","article-title":"Substrate specificity and the effect of calcium on Trypanosoma brucei metacaspase 2","volume":"280","author":"Machado","year":"2013","journal-title":"FEBS J"},{"key":"10.1016\/j.bmc.2021.116365_b0515","doi-asserted-by":"crossref","unstructured":"Vercammen D, De Cotte B Van, De Jaeger G, et al. Type II metacaspases Atmc4 and Atmc9 of Arabidopsis thaliana cleave substrates after arginine and lysine. J Biol Chem. Published online 2004. http:\/\/doi.org\/10.1074\/jbc.M406329200.","DOI":"10.1074\/jbc.M406329200"},{"key":"10.1016\/j.bmc.2021.116365_b0520","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1016\/j.febslet.2007.11.009","article-title":"Metacaspase 2 of Trypanosoma brucei is a calcium-dependent cysteine peptidase active without processing","volume":"581","author":"Moss","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bmc.2021.116365_b0525","author":"Tsiatsiani","year":"2011","journal-title":"Metacaspases Cell Death Differ Published online"},{"key":"10.1016\/j.bmc.2021.116365_b0530","article-title":"Classification and Nomenclature of Metacaspases and Paracaspases: No More Confusion with Caspases","author":"Minina","year":"2020","journal-title":"Mol Cell Published online"},{"key":"10.1016\/j.bmc.2021.116365_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/S1471-4922(03)00038-2","article-title":"Clan CD cysteine peptidases of parasitic protozoa","author":"Mottram","year":"2003","journal-title":"Trends Parasitol Published online"},{"key":"10.1016\/j.bmc.2021.116365_b0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.molbiopara.2005.09.001","article-title":"Metacaspases of Trypanosoma cruzi: Possible candidates for programmed cell death mediators","volume":"145","author":"Kosec","year":"2006","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bmc.2021.116365_b0545","doi-asserted-by":"crossref","DOI":"10.1128\/EC.00123-07","article-title":"Characterization of metacaspases with trypsin-like activity and their putative role in programmed cell death in the protozoan parasite Leishmania","author":"Lee","year":"2007","journal-title":"Eukaryot Cell Published online"},{"key":"10.1016\/j.bmc.2021.116365_b0550","article-title":"Serpin1 of Arabidopsis thaliana is a Suicide Inhibitor for Metacaspase 9","author":"Vercammen","year":"2006","journal-title":"J Mol Biol Published online"},{"key":"10.1016\/j.bmc.2021.116365_b0555","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1200885109","article-title":"Crystal structure of a Trypanosoma brucei metacaspase","author":"McLuskey","year":"2012","journal-title":"Proc Natl Acad Sci USA Published online"},{"key":"10.1016\/j.bmc.2021.116365_b0560","article-title":"Crystal structure of the yeast metacaspase Yca1","author":"Wong","year":"2012","journal-title":"J Biol Chem Published online"},{"key":"10.1016\/j.bmc.2021.116365_b0565","article-title":"Miltefosine induces metacaspase and PARP genes expression in Leishmania infantum","author":"Khademvatan","year":"2011","journal-title":"Brazilian J Infect Dis Published online"},{"key":"10.1016\/j.bmc.2021.116365_b0570","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M111.292334","article-title":"Trypanosoma brucei metacaspase 4 is a pseudopeptidase and a virulence factor","author":"Proto","year":"2011","journal-title":"J Biol Chem Published online"},{"key":"10.1016\/j.bmc.2021.116365_b0575","article-title":"Bloodstream form Trypanosoma brucei depend upon multiple metacaspases associated with RAB11-positive endosomes","author":"Helms","year":"2006","journal-title":"J Cell Sci Published online"},{"key":"10.1016\/j.bmc.2021.116365_b0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2017.01.002","article-title":"Processing of metacaspase 2 from Trypanosoma brucei (TbMCA2) broadens its substrate specificity","author":"Gilio","year":"2017","journal-title":"Biochim Biophys Acta - Proteins Proteomics Published online"},{"key":"10.1016\/j.bmc.2021.116365_b0585","doi-asserted-by":"crossref","DOI":"10.1016\/S0020-7519(03)00008-0","article-title":"Programmed cell death in trypanosomatids and other unicellular organisms","volume":"33","author":"Debrabant","year":"2003","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.bmc.2021.116365_b0590","doi-asserted-by":"crossref","DOI":"10.1038\/sj.cdd.4402232","article-title":"An essential role for the Leishmania major metacaspase in cell cycle progression","author":"Ambit","year":"2008","journal-title":"Cell Death Differ Published online"},{"key":"10.1016\/j.bmc.2021.116365_b0595","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.288","article-title":"Implication of different domains of the Leishmania major metacaspase in cell death and autophagy","author":"Casanova","year":"2015","journal-title":"Cell Death Dis Published online"},{"key":"10.1016\/j.bmc.2021.116365_b0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpara.2006.10.004","article-title":"Leishmania major metacaspase can replace yeast metacaspase in programmed cell death and has arginine-specific cysteine peptidase activity","author":"Gonz\u00e1lez","year":"2007","journal-title":"Int J Parasitol Published online"},{"key":"10.1016\/j.bmc.2021.116365_b0605","article-title":"Cysteine protease inhibitors as chemotherapy for parasitic infections. Bioorganic","volume":"7","author":"McKerrow","year":"1999","journal-title":"Med Chem"},{"key":"10.1016\/j.bmc.2021.116365_b0610","doi-asserted-by":"crossref","unstructured":"McKerrow JH. Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: Insights on safety, target validation, and mechanism of action. In: International Journal for Parasitology. Vol 29. ; 1999. http:\/\/doi.org\/10.1016\/S0020-7519(99)00044-2.","DOI":"10.1016\/S0020-7519(99)00044-2"},{"key":"10.1016\/j.bmc.2021.116365_b0615","article-title":"An in silico study of benzophenone derivatives as potential non-competitive inhibitors of trypanosoma cruzi and Leishmania amazonensis cysteine proteinases","volume":"29","author":"Freitas","year":"2018","journal-title":"J Braz Chem Soc"},{"key":"10.1016\/j.bmc.2021.116365_b0620","article-title":"Cysteine Proteinases of Trypanosome Parasites Novel Targets for Chemotherapy","volume":"1","author":"Caffrey","year":"2005","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.bmc.2021.116365_b0625","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00323-10","article-title":"In vitro and in vivo trypanocidal effects of the cyclopalladated compound 7a, a drug candidate for treatment of Chagas\u2019 disease","volume":"54","author":"Matsuo","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2021.116365_b0630","doi-asserted-by":"crossref","DOI":"10.1084\/jem.188.4.725","article-title":"Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection","volume":"188","author":"Engel","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.bmc.2021.116365_b0635","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00436-07","article-title":"A cysteine protease inhibitor cures Chagas\u2019 disease in an immunodeficient-mouse model of infection","volume":"51","author":"Doyle","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2021.116365_b0640","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.49.12.5160-5161.2005","article-title":"A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi","volume":"49","author":"Barr","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2021.116365_b0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2004.03.005","article-title":"Leishmania tropica: Cysteine proteases are essential for growth and pathogenicity","volume":"106","author":"Mahmoudzadeh-Niknam","year":"2004","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.bmc.2021.116365_b0650","article-title":"The path from target validation to the clinic","volume":"712","author":"Sajid","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.bmc.2021.116365_b0655","article-title":"Design, synthesis, biological evaluation and molecular modeling studies of novel eugenol esters as leishmanicidal agents","author":"Coelho","year":"2018","journal-title":"J Braz Chem Soc Published online"},{"key":"10.1016\/j.bmc.2021.116365_b0660","doi-asserted-by":"crossref","DOI":"10.1007\/s00044-017-1824-y","article-title":"Synthesis, protease inhibition, and antileishmanial activity of new benzoxazoles derived from acetophenone or benzophenone and synthetic precursors","volume":"26","author":"Folquitto","year":"2017","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmc.2021.116365_b0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2015.08.030","article-title":"Benzophenone derivatives as cysteine protease inhibitors and biological activity against Leishmania(L.) amazonensis amastigotes","volume":"75","author":"de Almeida","year":"2015","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmc.2021.116365_b0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2012.06.021","article-title":"Leishmanicidal, antiproteolytic and antioxidant evaluation of natural biflavonoids isolated from Garcinia brasiliensis and their semisynthetic derivatives","volume":"58","author":"Gontijo","year":"2012","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2021.116365_b0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2008.05.010","article-title":"Metal compounds for the treatment of parasitic diseases","volume":"102","author":"Fricker","year":"2008","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.bmc.2021.116365_b0680","doi-asserted-by":"crossref","DOI":"10.1590\/S0103-50532008000700018","article-title":"Palladium polypyridyl complexes: Synthesis, characterization, DNA interaction and biological activity on Leishmania (L.) mexicana","volume":"19","author":"Navarro","year":"2008","journal-title":"J Braz Chem Soc"},{"key":"10.1016\/j.bmc.2021.116365_b0685","article-title":"Chiral cyclopalladated complexes derived from N, N-dimethyl-1-phenethylamine with bridging bis(diphenylphosphine)ferrocene ligand as inhibitors of the cathepsin B activity and as antitumoral agents","volume":"13","author":"Bincoletto","year":"2005","journal-title":"Bioorganic MedChem"},{"key":"10.1016\/j.bmc.2021.116365_b0690","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001626","article-title":"In vitro and in vivo activity of a palladacycle complex on Leishmania (Leishmania) amazonensis","volume":"6","author":"de Paladi","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmc.2021.116365_b0695","doi-asserted-by":"crossref","unstructured":"Pimentel IAS, Paladi C de S, Katz S, J\u00fadice WA de S, Cunha RLOR, Barbi\u00e9ri CL. In Vitro and In Vivo Activity of an Organic Tellurium Compound on Leishmania (Leishmania) chagasi. PLoS One. 2012;7(11). http:\/\/doi.org\/10.1371\/journal.pone.0048780.","DOI":"10.1371\/journal.pone.0048780"},{"key":"10.1016\/j.bmc.2021.116365_b0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115511","article-title":"Cytotoxicity of 4-substituted quinoline derivatives: Anticancer and antileishmanial potential","volume":"28","author":"Costa","year":"2020","journal-title":"Bioorganic Med Chem"},{"key":"10.1016\/j.bmc.2021.116365_b0705","doi-asserted-by":"crossref","DOI":"10.1016\/0014-5793(89)81655-2","article-title":"A cysteine proteinase cDNA from Trypanosoma brucei predicts an enzyme with an unusual C-terminal extension","volume":"258","author":"Mottram","year":"1989","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bmc.2021.116365_b0710","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/18.20.6141","article-title":"Cloning and sequencing of the cysteine protease cDNA from Trypanosoma brucei rhodesiense","volume":"18","author":"Pamer","year":"1990","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2021.116365_b0715","doi-asserted-by":"crossref","DOI":"10.1016\/0014-5793(92)81382-V","article-title":"Characterization of a multi-copy gene for a major stage-specific cysteine proteinase of Leishmania mexicana","volume":"311","author":"Souza","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bmc.2021.116365_b0720","doi-asserted-by":"crossref","DOI":"10.1016\/0166-6851(93)90248-V","article-title":"Identification of two distinct cysteine proteinase genes of Leishmania pifanoi axenic amastigotes using the polymerase chain reaction","volume":"57","author":"Traub-Cseko","year":"1993","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bmc.2021.116365_b0725","doi-asserted-by":"crossref","unstructured":"Murta ACM, Persechini PM, Padron T de S, de Souza W, Guimar\u00e3es JA, Scharfstein J. Structural and functional identification of GP57\/51 antigen of Trypanosoma cruzi as a cysteine proteinase. Mol Biochem Parasitol. 1990;43(1). http:\/\/doi.org\/10.1016\/0166-6851(90)90127-8.","DOI":"10.1016\/0166-6851(90)90127-8"},{"key":"10.1016\/j.bmc.2021.116365_b0730","doi-asserted-by":"crossref","DOI":"10.1016\/0166-6851(92)90219-A","article-title":"The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is encoded by multiple polymorphic tandemly organized genes located on different chromosomes","volume":"50","author":"Campetella","year":"1992","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bmc.2021.116365_b0735","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.137.4.1336","article-title":"Trypanosoma cruzi: Characterization and isolation of A 57\/51,000 m.w. surface glycoprotein (GP57\/51) expressed by epimastigotes and bloodstream trypomastigotes","volume":"137","author":"Scharfstein","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.bmc.2021.116365_b0740","doi-asserted-by":"crossref","DOI":"10.2174\/092986709788802971","article-title":"Cruzipain, the Major Cysteine Protease of Trypanosoma cruzi: A Sulfated Glycoprotein Antigen as Relevant Candidate for Vaccine Development and Drug Target. A Review","volume":"16","author":"Duschak","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2021.116365_b0745","article-title":"Cruzipain, the major cysteine proteinase from the protozoan parasite Trypanosoma cruzi","volume":"378","author":"Cazzulo","year":"1997","journal-title":"Biol Chem"},{"key":"10.1016\/j.bmc.2021.116365_b0750","doi-asserted-by":"crossref","DOI":"10.1111\/j.1574-6968.1994.tb07265.x","article-title":"Effects of proteinase inhibitors on the growth and differentiation of Trypanosoma cruzi","volume":"124","author":"Franke de Cazzulo","year":"1994","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.bmc.2021.116365_b0755","doi-asserted-by":"crossref","DOI":"10.1016\/0166-6851(92)90050-T","article-title":"Inhibitors of the major cysteinyl proteinase (GP57\/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro","volume":"52","author":"Meirelles","year":"1992","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bmc.2021.116365_b0760","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20071742","article-title":"Structure-based virtual screening and in vitro evaluation of new trypanosoma cruzi cruzain inhibitors","volume":"20","author":"Herrera-Mayorga","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2021.116365_b0765","article-title":"Cruzipain, a major Trypanosoma cruzi cystein protease in the host-parasite interplay","volume":"25","author":"Gea","year":"2006","journal-title":"Inmunologia"},{"key":"10.1016\/j.bmc.2021.116365_b0770","doi-asserted-by":"crossref","DOI":"10.1016\/0006-291X(90)92179-4","article-title":"Lysis of trypanosomes by peptidyl fluoromethyl ketones","volume":"170","author":"Ashall","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2021.116365_b0775","doi-asserted-by":"crossref","DOI":"10.2174\/092986708783330683","article-title":"Virtual Screening and Its Integration with Modern Drug Design Technologies","volume":"15","author":"Andricopulo","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2021.116365_b0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2004.10.023","article-title":"Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzain","volume":"15","author":"Fujii","year":"2005","journal-title":"Bioorganic Med Chem Lett"},{"key":"10.1016\/j.bmc.2021.116365_b0785","doi-asserted-by":"crossref","DOI":"10.1002\/pro.5560060801","article-title":"Structural determinants of specificity in the cysteine protease cruzain","volume":"6","author":"Gillmor","year":"1997","journal-title":"Protein Sci"},{"key":"10.1016\/j.bmc.2021.116365_b0790","doi-asserted-by":"crossref","DOI":"10.1021\/ja710254m","article-title":"Identification of a new class of nonpeptidic inhibitors of cruzain","volume":"130","author":"Brak","year":"2008","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2021.116365_b0795","doi-asserted-by":"crossref","DOI":"10.1590\/S0103-50532010000100021","article-title":"Biochemical evaluation of a series of synthetic chalcone and hydrazide derivatives as novel inhibitors of cruzain from trypanosoma cruzi","volume":"21","author":"Borchhardt","year":"2010","journal-title":"J Braz Chem Soc"},{"key":"10.1016\/j.bmc.2021.116365_b0800","doi-asserted-by":"crossref","DOI":"10.1021\/jm100488w","article-title":"Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors","volume":"53","author":"Ferreira","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116365_b0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2015.06.048","article-title":"Synthesis and structure-activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain","volume":"101","author":"Esp\u00edndola","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2021.116365_b0810","doi-asserted-by":"crossref","DOI":"10.1016\/S1074-5521(00)00018-1","article-title":"Aryl ureas represent a new class of anti-trypanosomal agents","volume":"7","author":"Du","year":"2000","journal-title":"Chem Biol"},{"key":"10.1016\/j.bmc.2021.116365_b0815","doi-asserted-by":"crossref","unstructured":"Roush WR, Hernandez AA, McKerrow JH, Selzer PM, Hansell E, Engel JC. Design, synthesis and evaluation of D-Homophenylalanyl epoxysuccinate inhibitors of the trypanosomal cysteine protease cruzain. In: Tetrahedron. Vol 56. ; 2000. http:\/\/doi.org\/10.1016\/S0040-4020(00)00882-6.","DOI":"10.1016\/S0040-4020(00)00882-6"},{"key":"10.1016\/j.bmc.2021.116365_b0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2010.10.015","article-title":"Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease","volume":"20","author":"Beaulieu","year":"2010","journal-title":"Bioorganic Med Chem Lett"},{"key":"10.1016\/j.bmc.2021.116365_b0825","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1016\/j.bmc.2018.07.015","article-title":"Antiprotozoal and cysteine proteases inhibitory activity of dipeptidyl enoates","volume":"26","author":"Royo","year":"2018","journal-title":"Bioorganic Med Chem"},{"key":"10.1016\/j.bmc.2021.116365_b0830","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.201500204","article-title":"Dipeptidyl Enoates As Potent Rhodesain Inhibitors That Display a Dual Mode of Action","volume":"10","author":"Royo","year":"2015","journal-title":"Chem Med Chem"},{"key":"10.1016\/j.bmc.2021.116365_b0835","doi-asserted-by":"crossref","DOI":"10.1021\/acsmedchemlett.6b00276","article-title":"Dipeptidyl Nitroalkenes as Potent Reversible Inhibitors of Cysteine Proteases Rhodesain and Cruzain","volume":"7","author":"Latorre","year":"2016","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2021.116365_b0840","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.201300112","article-title":"Optimization of Triazine Nitriles as Rhodesain Inhibitors: Structure-Activity Relationships, Bioisosteric Imidazopyridine Nitriles, and X-ray Crystal Structure Analysis with Human CathepsinL","volume":"8","author":"Ehmke","year":"2013","journal-title":"Chem Med Chem"},{"key":"10.1016\/j.bmc.2021.116365_b0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2006.02.026","article-title":"Aziridine-2,3-dicarboxylate inhibitors targeting the major cysteine protease of Trypanosoma brucei as lead trypanocidal agents","volume":"16","author":"Vicik","year":"2006","journal-title":"Bioorganic Med Chem Lett"},{"key":"10.1016\/j.bmc.2021.116365_b0850","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01430-05","article-title":"Aziridine-2,3-dicarboxylates, peptidomimetic cysteine protease inhibitors with antileishmanial activity","volume":"50","author":"Ponte-Sucre","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2021.116365_b0855","doi-asserted-by":"crossref","unstructured":"De Souza ML, De Oliveira Rezende Junior C, Ferreira RS, et al. Discovery of Potent, Reversible, and Competitive Cruzain Inhibitors with Trypanocidal Activity: A Structure-Based Drug Design Approach. J Chem Inf Model. 2020;60(2). http:\/\/doi.org\/10.1021\/acs.jcim.9b00802.","DOI":"10.1021\/acs.jcim.9b00802"},{"key":"10.1016\/j.bmc.2021.116365_b0860","doi-asserted-by":"crossref","DOI":"10.1021\/jm901633v","article-title":"Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for chagas disease chemotherapy","volume":"53","author":"Brak","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116365_b0865","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000825","article-title":"In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi","volume":"4","author":"Chen","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmc.2021.116365_b0870","doi-asserted-by":"crossref","DOI":"10.1021\/acsmedchemlett.5b00336","article-title":"Synthesis and Evaluation of Oxyguanidine Analogues of the Cysteine Protease Inhibitor WRR-483 against Cruzain","volume":"7","author":"Jones","year":"2016","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2021.116365_b0875","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01855-13","article-title":"Reversible cysteine protease inhibitors show promise for a chagas disease cure","volume":"58","author":"Ndao","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2021.116365_b0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2006.03.021","article-title":"Antileishmanial activity of MDL 28170, a potent calpain inhibitor","volume":"28","author":"d\u2019Avila-Levy","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bmc.2021.116365_b0885","doi-asserted-by":"crossref","DOI":"10.1017\/S0031182009005629","article-title":"Arrested growth of Trypanosoma cruzi by the calpain inhibitor MDL28170 and detection of calpain homologues in epimastigote forms","volume":"136","author":"Sangenito","year":"2009","journal-title":"Parasitology"},{"key":"10.1016\/j.bmc.2021.116365_b0890","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkq154","article-title":"Effects of the calpain inhibitor MDL28170 on the clinically relevant forms of Trypanosoma cruzi in vitro","volume":"65","author":"Ennes-Vidal","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmc.2021.116365_b0895","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018371","article-title":"MDL28170, a calpain inhibitor, affects Trypanosoma cruzi metacyclogenesis, ultrastructure and attachment to Rhodnius prolixus midgut","volume":"6","author":"Ennes-Vidal","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmc.2021.116365_b0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2010.01.099","article-title":"Design and evaluation of Trypanosoma brucei metacaspase inhibitors","author":"Berg","year":"2010","journal-title":"Bioorganic Med Chem Lett Published online"},{"key":"10.1016\/j.bmc.2021.116365_b0905","doi-asserted-by":"crossref","unstructured":"de Castro E, Reus TL, de Aguiar AM, \u00c1vila AR, de Arruda Campos Brasil de Souza T. Procaspase-activating compound-1 induces apoptosis in Trypanosoma cruzi. Apoptosis. 2017;22(12). http:\/\/doi.org\/10.1007\/s10495-017-1428-5.","DOI":"10.1007\/s10495-017-1428-5"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621003734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621003734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:16:22Z","timestamp":1760836582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089621003734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":181,"alternative-id":["S0968089621003734"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116365","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cysteine proteases as potential targets for anti-trypanosomatid drug discovery","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116365"}}